Isentress-H-C-PSUSA-00010373-202009: EPAR : Scientific conclusions and grounds for the variation to the terms of the marketing authorisation(s)
Isentress-H-C-PSUSA-00010373-202009: EPAR : Scientific conclusions and grounds for the variation to the terms of the marketing authorisation(s)
Advanced pharmaceutical formulation for targeted therapeutic intervention.
Dosage
Isentress-H-C-PSUSA-00010373-202009: EPAR : Scientific conclusions and grounds for the variation to the terms of the marketing authorisation(s)
Strength
Isentress-H-C-PSUSA-00010373-202009: EPAR : Scientific conclusions and grounds for the variation to the terms of the marketing authorisation(s)
Pack Size
Isentress-H-C-PSUSA-00010373-202009: EPAR : Scientific conclusions and grounds for the variation to the terms of the marketing authorisation(s)
Form
Isentress-H-C-PSUSA-00010373-202009: EPAR : Scientific conclusions and grounds for the variation to the terms of the marketing authorisation(s)
Source
European Medicines Agency
Safety Profile
Contraindications
Side Effects
Scan this QR code to access this page quickly on your mobile device.